Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Hepatitis

Free Subscription 10.06.2019 1 AIDS 1 Am J Epidemiol 1 Clin Infect Dis 2 Eur J Gastroenterol Hepatol 1 Int J STD AIDS 2 J Hepatol 2 J Infect Dis 2 J Interferon Cytokine Res 2 J Med Virol 2 J Virol 8 PLoS One 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AIDS

1. MBAE M, Owen L, Elisha KK, Ndhere A, et al
   Excess early mortality in HIV/hepatitis B virus co-infected patients initiating antiretroviral therapy in Kenya.
   AIDS. 2019;33:1404-1406.
   PubMed     Text format    
   
   

   
   Am J Epidemiol

2. FRASER H, Vellozzi C, Hoerger TJ, Evans JL, et al
   Scaling-up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States - a Rural and Urban Comparison.
   Am J Epidemiol. 2019 May 31. pii: 5509380. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Clin Infect Dis

3. LIN KY, Sun HY, Chen YH, Lo YC, et al
   Effect of a hepatitis A vaccination campaign during a hepatitis A outbreak in Taiwan, 2015-2017: a modeling study.
   Clin Infect Dis. 2019 Jun 3. pii: 5510337. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Gastroenterol Hepatol

4. YU ZJ, Zhang LL, Huang TT, Zhu JS, et al
   Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta-analysis.
   Eur J Gastroenterol Hepatol. 2019;31:873-877.
   PubMed     Text format     Abstract available
   
   
5. HANAFY AS, Seleem WM, Basha MAA, Marei AM, et al
   Residual hepatitis C virus in peripheral blood mononuclear cell as a risk factor for hepatocellular carcinoma after achieving a sustained virological response: a dogma or fiction.
   Eur J Gastroenterol Hepatol. 2019 May 29. doi: 10.1097/MEG.0000000000001459.
   PubMed     Text format     Abstract available
   
   

   
   Int J STD AIDS

6. MA J, Non L, Amornsawadwattana S, Olsen MA, et al
   Hepatitis C care cascade in HIV patients at an urban clinic in the early direct-acting antiviral era.
   Int J STD AIDS. 2019 Jun 3:956462419832750. doi: 10.1177/0956462419832750.
   PubMed     Text format     Abstract available
   
   

   
   J Hepatol

7. GOTLIEB N, Moradpour D, Shouval D
   Hepatitis A and E - differences and commonalities.
   J Hepatol. 2019 Jun 4. pii: S0168-8278(19)30297.
   PubMed     Text format    
   
   
8. WILSON E, Covert E, Hoffmann J, Comstock E, et al
   A Pilot Study of Safety and Efficacy of HCV Retreatment with sofosbuvir/velpatasvir/voxilaprevir in Patients With or Without HIV (RESOLVE STUDY).
   J Hepatol. 2019 Jun 4. pii: S0168-8278(19)30307.
   PubMed     Text format     Abstract available
   
   

   
   J Infect Dis

9. OLBRICH A, Wardemann H, Bohm S, Rother K, et al
   Repertoire and neutralizing activity of antibodies against E2 peptide in patients with spontaneous resolution of hepatitis C.
   J Infect Dis. 2019 Jun 4. pii: 5511345. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
10. HAN JW, Sung PS, Kim KH, Hong SH, et al
    Dynamic Changes in Ex Vivo T-Cell Function after Viral Clearance in Chronic HCV Infection.
    J Infect Dis. 2019 Jun 1. pii: 5510067. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Interferon Cytokine Res

11. ABOUSHADY M, Alwassief A, Abdelrazik M, Ziada D, et al
    Retreatment of Egyptian Chronic Hepatitis C Patients Not Responding to Pegylated Interferon and Ribavirin Dual Therapy.
    J Interferon Cytokine Res. 2019 Jun 6. doi: 10.1089/jir.2019.0041.
    PubMed     Text format     Abstract available
    
    
12. O'BRIEN TR, Jackson SS
    What Have We Learned from Studies of IFN-lambda Variants and HCV Infection?
    J Interferon Cytokine Res. 2019 Jun 4. doi: 10.1089/jir.2019.0048.
    PubMed     Text format     Abstract available
    
    

    
    J Med Virol

13. GRECO L, Renteria SCU, Guarneri D, Orlandi A, et al
    HEV and HAV seroprevalence in men that have sex with men (MSM): an update from Milan, Italy.
    J Med Virol. 2018 Feb 15. doi: 10.1002/jmv.25052.
    PubMed     Text format     Abstract available
    
    
14. MARASCIO N, Pavia G, Romeo I, Talarico C, et al
    Real-life 3D therapy failure: Analysis of NS5A 93H RAS plus 108 K polymorphism in complex with ombitasvir by molecular modeling.
    J Med Virol. 2018 Mar 25. doi: 10.1002/jmv.25073.
    PubMed     Text format     Abstract available
    
    

    
    J Virol

15. KORNYEYEV D, Ramakrishnan D, Voitenleitner C, Livingston CM, et al
    Spatiotemporal Analysis of Hepatitis B Virus X Protein in Primary Human Hepatocytes.
    J Virol. 2019 Jun 5. pii: JVI.00248-19. doi: 10.1128/JVI.00248.
    PubMed     Text format     Abstract available
    
    
16. RAMAKRISHNAN D, Xing W, Beran RK, Chemuru S, et al
    Hepatitis B Virus X Protein Function Requires Zinc Binding.
    J Virol. 2019 Jun 5. pii: JVI.00250-19. doi: 10.1128/JVI.00250.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

17. RODRIGUEZ-OSORIO I, Mena A, Meijide H, Morano L, et al
    Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals.
    PLoS One. 2019;14:e0217052.
    PubMed     Text format     Abstract available
    
    
18. COFFIN PO, Santos GM, Behar E, Hern J, et al
    Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs.
    PLoS One. 2019;14:e0217471.
    PubMed     Text format     Abstract available
    
    
19. MEDIC S, Anastassopoulou C, Milosevic V, Dragnic N, et al
    Declining seroprevalence of hepatitis A in Vojvodina, Serbia.
    PLoS One. 2019;14:e0217176.
    PubMed     Text format     Abstract available
    
    
20. ROBERTS H, Boktor SW, Waller K, Daar ZS, et al
    Underreporting of Hepatitis B and C virus infections - Pennsylvania, 2001-2015.
    PLoS One. 2019;14:e0217455.
    PubMed     Text format     Abstract available
    
    
21. GASTALDI G, Gomes D, Schneiter P, Montet X, et al
    Treatment with direct-acting antivirals improves peripheral insulin sensitivity in non-diabetic, lean chronic hepatitis C patients.
    PLoS One. 2019;14:e0217751.
    PubMed     Text format     Abstract available
    
    
22. CHAILLON A, Mehta SR, Hoenigl M, Solomon SS, et al
    Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection.
    PLoS One. 2019;14:e0217964.
    PubMed     Text format     Abstract available
    
    
23. WILHELM B, Waddell L, Greig J, Young I, et al
    Systematic review and meta-analysis of the seroprevalence of hepatitis E virus in the general population across non-endemic countries.
    PLoS One. 2019;14:e0216826.
    PubMed     Text format     Abstract available
    
    
24. PRABDIAL-SING N, Makhathini L, Smit SB, Manamela MJ, et al
    Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance.
    PLoS One. 2019;14:e0217415.
    PubMed     Text format     Abstract available
    
    

    
    Vaccine

25. YU W, Lee LA, Liu Y, Scherpbier RW, et al
    Vaccine-preventable disease control in the People's Republic of China: 1949-2016.
    Vaccine. 2018 Nov 26. pii: S0264-410X(18)31357.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: